Post-treatment with the PPAR-γ agonist pioglitazone inhibits inflammation and bacterial growth during Klebsiella pneumonia.

2 A) and inflammatory mediators and MPO levels in lungs, although the difference between groups did not reach statistical significance for IL-6 and IL-1β (Fig. 2 B).

also in 111,027 other papers